Pharmaceutical specialties in the U.S.--a note about the PDR 1972

Anthropometric measures and their association with risk factors for cardio-metabolic diseases in Kenyan adults.

Annals of human biology·2019

FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: basal contents and effects of psychotropic treatments.

Neuroscience·2014

Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.

Neuroscience·2013

Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.

Translational psychiatry·2013

Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.

Psychopharmacology·2012

Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.

Neuroscience·2012

Safety, Pharmacokinetics, Food effect, and Pharmacodynamics of AJM347, a Selective α4β7 Integrin Antagonist: A First-in-Human Single- and Multiple-Ascending Dose Study in Healthy Male Volunteers.

Journal of clinical pharmacology·2026

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.

Journal of clinical pharmacology·2026

PBPK Modeling of Esomeprazole to Support Adolescent Pharmacokinetic Extrapolation and Label Extension in Chinese Patients With Gastroesophageal Reflux Disease (GERD).

Journal of clinical pharmacology·2026

Bayesian-Estimated Vancomycin AUC24 as a Near-Term Renal Risk Signal after Therapeutic Drug Monitoring: A Multicenter Cohort Study.

Journal of clinical pharmacology·2026

Tamoxifen Therapy Is Associated With Altered Intestinal P-Glycoprotein Activity In Vivo.

Journal of clinical pharmacology·2026

Safety, Tolerability, and Pharmacokinetics of Oral Camlipixant: A Randomized First-In-Human Study Using Single and Multiple Ascending Doses.

Journal of clinical pharmacology·2026

Development of a park and green space service classification to support park prescribing in Korea.

Frontiers in public health·2026

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta-analysis.

British journal of clinical pharmacology·2026

The Impact of clinical pharmacy services within an oncology Center of excellence on patient outcomes and cost efficiency.

Expert review of pharmacoeconomics & outcomes research·2026

Evaluation of a triage model for pharmacist review of medication histories collected by pharmacy technicians in the emergency department.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Retail vs Mail Order Drug Prescribing: Trends and Costs in the Workers' Compensation System - A Preliminary Study Using Pharmacy Benefit Management Data for Ankle Sprain Claims.

Journal of occupational and environmental medicine·2026

Improving Hospitalist Prescription Drug Monitoring Program Review for Safer Opioid Prescribing: A Quality Improvement Initiative.

Journal for healthcare quality : official publication of the National Association for Healthcare Quality·2026

Related Experiment Videos

Pharmaceutical specialties in the U.S.--a note about the PDR 1972

Related Concept Videos

Anthropometric measures and their association with risk factors for cardio-metabolic diseases in Kenyan adults.

FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: basal contents and effects of psychotropic treatments.

Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.

Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.

Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.

Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.

Safety, Pharmacokinetics, Food effect, and Pharmacodynamics of AJM347, a Selective α4β7 Integrin Antagonist: A First-in-Human Single- and Multiple-Ascending Dose Study in Healthy Male Volunteers.

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.

PBPK Modeling of Esomeprazole to Support Adolescent Pharmacokinetic Extrapolation and Label Extension in Chinese Patients With Gastroesophageal Reflux Disease (GERD).

Bayesian-Estimated Vancomycin AUC24 as a Near-Term Renal Risk Signal after Therapeutic Drug Monitoring: A Multicenter Cohort Study.

Tamoxifen Therapy Is Associated With Altered Intestinal P-Glycoprotein Activity In Vivo.

Safety, Tolerability, and Pharmacokinetics of Oral Camlipixant: A Randomized First-In-Human Study Using Single and Multiple Ascending Doses.

Development of a park and green space service classification to support park prescribing in Korea.

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta-analysis.

The Impact of clinical pharmacy services within an oncology Center of excellence on patient outcomes and cost efficiency.

Evaluation of a triage model for pharmacist review of medication histories collected by pharmacy technicians in the emergency department.

Retail vs Mail Order Drug Prescribing: Trends and Costs in the Workers' Compensation System - A Preliminary Study Using Pharmacy Benefit Management Data for Ankle Sprain Claims.

Improving Hospitalist Prescription Drug Monitoring Program Review for Safer Opioid Prescribing: A Quality Improvement Initiative.

Related Experiment Videos

Pharmaceutical specialties in the U.S.--a note about the PDR 1972

Related Concept Videos

Related Articles